[{"NetIncomeLoss_1_Q1_USD":-22215181.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":16572672.0,"CommitmentsAndContingencies_0_Q1_USD":null,"InterestIncomeOther_1_Q1_USD":11500.0,"AccruedLiabilitiesCurrent_0_Q1_USD":4636584.0,"InterestPaidNet_1_Q1_USD":null,"IncomeTaxesPaid_1_Q1_USD":null,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":15465841.0,"Depreciation_1_Q1_USD":806.0,"GeneralAndAdministrativeExpense_1_Q1_USD":8382976.0,"PaymentsToAcquireInvestments_1_Q1_USD":20663535.0,"ExcessStockSharesAuthorized_0_Q1_shares":13000.0,"AssetsCurrent_0_Q1_USD":103775602.0,"AccruedVacationCurrent_0_Q1_USD":401200.0,"ContractualObligationDueInNextTwelveMonths_0_Q1_USD":79200.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":7963129.0,"LeaseAndRentalExpense_1_Q1_USD":15900.0,"CommonStockSharesIssued_0_Q1_shares":16748055.0,"Assets_0_Q1_USD":103866508.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1_Q1_shares":1500000.0,"PreferredStockSharesOutstanding_0_Q1_shares":null,"ContractualObligationDueInSecondYear_0_Q1_USD":null,"LeaseIncome_1_Q1_USD":3300.0,"ClassOfWarrantOrRightOutstanding_0_Q1_shares":48182.0,"ResearchAndDevelopmentExpense_1_Q1_USD":14022227.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":87505.0,"PrepaidExpenseCurrent_0_Q1_USD":990695.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":379601.0,"CommonStockValue_0_Q1_USD":16748.0,"ProceedsFromIssuanceOrSaleOfEquity_1_Q1_USD":19791644.0,"PrepaidExpenseCurrentAndNoncurrent_0_Q1_USD":990700.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":1928279.0,"RealizedInvestmentGainsLosses_1_Q1_USD":-52789.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":102703774.0,"OtherPrepaidExpenseCurrent_0_Q1_USD":171600.0,"FairValueAdjustmentOfWarrants_1_Q1_USD":1928279.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":4636600.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-263679.0,"AccruedBonusesCurrentAndNoncurrent_0_Q1_USD":365200.0,"OtherAssetsNoncurrent_0_Q1_USD":25000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":3804042.0,"DefinedContributionPlanCostRecognized_1_Q1_USD":40320.0,"UnrealizedGainLossOnInvestments_1_Q1_USD":-177163.0,"GainLossOnSaleOfInvestments_1_Q1_USD":-36129376.0,"ShareBasedCompensation_1_Q1_USD":5851284.0,"ContractualObligation_0_Q1_USD":79200.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":2383080.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":16200.0,"InterestIncomeExpenseNet_1_Q1_USD":419974.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-16085475.0,"ProceedsFromWarrantExercises_1_Q1_USD":1460506.0,"LiabilitiesCurrent_0_Q1_USD":12719380.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":1308645.0,"AccountsPayableCurrent_0_Q1_USD":8082796.0,"NonoperatingIncomeExpense_1_Q1_USD":190022.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":467773.0,"IncreaseDecreaseInOtherReceivables_1_Q1_USD":null,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":344600.0,"ProceedsFromFeesReceived_1_Q1_USD":367800.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q1_USD":61100000.0,"AdditionalPaidInCapital_0_Q1_USD":292660864.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_0_Q1_shares":2797142.0,"PrepaidInsurance_0_Q1_USD":353700.0,"PreferredStockSharesIssued_0_Q1_shares":null,"PropertyPlantAndEquipmentNet_0_Q1_USD":452.0,"IncreaseDecreaseInLeasingReceivables_1_Q1_USD":-19247.0,"ShortTermInvestments_0_Q1_USD":98899732.0,"CommonStockSharesOutstanding_0_Q1_shares":16748055.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_1_Q1_USD":5851284.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"RepaymentsOfNotesPayable_1_Q1_USD":null,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_1_Q1_shares":400000.0,"CommonStockSharesAuthorized_0_Q1_shares":50000000.0,"OperatingIncomeLoss_1_Q1_USD":-22405203.0,"PreferredStockValue_0_Q1_USD":null,"LiabilitiesAndStockholdersEquity_0_Q1_USD":103866508.0,"PreferredStockSharesAuthorized_0_Q1_shares":200000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":5851300.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_1_Q1_shares":273491.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":16700.0,"OperatingExpenses_1_Q1_USD":22405203.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.34,"ProfitLoss_1_Q1_USD":-22215181.0,"StockholdersEquity_0_Q1_USD":91147128.0,"LeaseIncentiveReceivableNoncurrent_0_Q1_USD":65454.0,"LeaseIncentiveReceivableCurrent_0_Q1_USD":81133.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-201530484.0,"ContractualObligationDueAfterFifthYear_0_Q1_USD":null,"AccruedProfessionalFeesCurrent_0_Q1_USD":149000.0,"Ticker":"RLMD","CIK":"1553643","name":"RELMADA THERAPEUTICS, INC.","OfficialName":"Relmada Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"772606380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210512"}]